Molecular docking of an antianxiety drug molecule "3-[2-(1H-Benzimidazol-2-ylsulfan-yl) eth-yl]-1, 3-oxazolidin-2-one" - researchr publication authors

researchr

You are not signed in
Sign in
Sign up

Abdellatif Bouayyadi, Aissam El Aliani, Yassine Kasmi, Ahmed Moussaif, Abdelhalim Mesfioui, El Mokhtar Essassi, Mohammed El Mzibri. Molecular docking of an antianxiety drug molecule "3-[2-(1H-Benzimidazol-2-ylsulfan-yl) eth-yl]-1, 3-oxazolidin-2-one". I. J. Computational Biology and Drug Design, 15(1):30-42, 2022. [doi]

This author has not been identified. Look up 'Abdellatif Bouayyadi' in GoogleThis author has not been identified. Look up 'Aissam El Aliani' in GoogleThis author has not been identified. Look up 'Yassine Kasmi' in GoogleThis author has not been identified. Look up 'Ahmed Moussaif' in GoogleThis author has not been identified. Look up 'Abdelhalim Mesfioui' in GoogleThis author has not been identified. Look up 'El Mokhtar Essassi' in GoogleThis author has not been identified. Look up 'Mohammed El Mzibri' in Google

runs on WebDSL